ARTICLE | Company News
Medytox, Allergan deal
January 13, 2014 8:00 AM UTC
The companies closed a September 2013 licensing deal granting Allergan exclusive, worldwide rights outside of Korea to develop and commercialize undisclosed neurotoxin products from Medytox (see BioCe...